Compare AU

Compare DRUG vs. IBUY

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the BetaShares Online Retail and E-Commerce ETF (IBUY). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

IBUY

Popularity

Low

Low

Pearlers invested

63

8

Median incremental investment

$967.00

$504.29

Median investment frequency

Monthly

Monthly

Median total investment

$1,875.72

$885.78

Average age group

26 - 35

> 35


Key Summary

DRUG

IBUY

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

IBUY.AX was created on 2022-02-14 by BetaShares. The fund's investment portfolio concentrates primarily on consumer discretionary equity. IBUY.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to a portfolio of the worlds leading online retailers.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

TENCENT HOLDINGS LTD (6.91 %)

PDD HOLDINGS INC (6.57 %)

BOOKING HOLDINGS INC (6.49 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Consumer Discretionary (39.35 %)

Other (34.07 %)

Communication Services (12.09 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

United States (47.12 %)

China (32.18 %)

Brazil (5.08 %)

Management fee

0.57 %

0.67 %


Key Summary

DRUG

IBUY

Issuer

BetaShares

BetaShares

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Solactive EQM Online Retail and E-Commerce Index - AUD - Benchmark TR Net

Asset class

ETF

ETF

Management fee

0.57 %

0.67 %

Price

$8.12

$15.54

Size

$182.401 million

$3.180 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.90 %

- %

Market

ASX

ASX

First listed date

08/08/2016

15/02/2022

Purchase fee

$6.50

$6.50


Community Stats

DRUG

IBUY

Popularity

Low

Low

Pearlers invested

63

8

Median incremental investment

$967.00

$504.29

Median investment frequency

Monthly

Monthly

Median total investment

$1,875.72

$885.78

Average age group

26 - 35

> 35


Pros and Cons

DRUG

IBUY

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

  • Higher exposure to AU market

Cons

  • Lower exposure to AU market

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

DRUG

IBUY

Lower exposure to AU market

Higher exposure to AU market

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home